How Wealthy Joe Made 127%

So – we’ve reached another end to a quarter, and I wanted to update you on how the Wealthy Joe investment fund is doing.

Truth be told, we currently only have two stocks in the fund. But they both have done pretty well!

The fund’s objective is to invest in disruptive innovation. We try to find companies that are innovating and disrupting the way things are currently being done.

Now, when you invest in this type of company, you will have to endure extreme volatility.

Disruptively innovative companies can fall hard during periods of market sell-off. It’s not uncommon for them to fall 20%, 305, or even 50%.

So…what are the two companies we chose?

1. The Trade Desk (NASDAQ: TTD): Performance +328%.

The Trade Desk operates a cloud-based technology platform that lets ad buyers optimize their spending, getting the right ads in front of the right person at the right time.

2. Ziopharm Oncology (NASDAQ: ZIOP): Performance +51%.

Ziopharm is a developmental biotechnology company engaged in the development and commercialization of small molecules and synthetic biology approaches to new cancer therapies.

As you can see, both stocks have been great performers for Wealthy Joe. The Trade Desk has been phenomenal!

I wish I could say that I knew this would happen. But I didn’t.

I learned about these companies a few years ago and liked their stories, so I took a chance.

That’s pretty much my thought process for both purchases.

The reason we publish our returns is so you can follow the progress of a real portfolio and see the ups and downs a portfolio will move over time.


My book, The Stock Market is For Everyone, is a short guide for the beginning, inexperienced investor that is easy to understand and can be put into action immediately.

Click the image of the book at left to be taken to its Amazon page.  (Disclosure: As a participant in the Amazon Services LLC Associates Program, I earn a small commission on each sale generated through these links.)

Leave a Reply